BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 7694906)

  • 1. Comorbidity of axis I and axis II disorders.
    Oldham JM; Skodol AE; Kellman HD; Hyler SE; Doidge N; Rosnick L; Gallaher PE
    Am J Psychiatry; 1995 Apr; 152(4):571-8. PubMed ID: 7694906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comorbidity of borderline personality disorder and other DSM-III-R axis II personality disorders.
    Nurnberg HG; Raskin M; Levine PE; Pollack S; Siegel O; Prince R
    Am J Psychiatry; 1991 Oct; 148(10):1371-7. PubMed ID: 1897619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axis I comorbidity of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Dubo ED; Sickel AE; Trikha A; Levin A; Reynolds V
    Am J Psychiatry; 1998 Dec; 155(12):1733-9. PubMed ID: 9842784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of DSM-III-R personality disorders by two structured interviews: patterns of comorbidity.
    Oldham JM; Skodol AE; Kellman HD; Hyler SE; Rosnick L; Davies M
    Am J Psychiatry; 1992 Feb; 149(2):213-20. PubMed ID: 1734742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity of DSM-III-R axis I and II disorders among female inpatients with eating disorders.
    Grilo CM; Levy KN; Becker DF; Edell WS; McGlashan TH
    Psychiatr Serv; 1996 Apr; 47(4):426-9. PubMed ID: 8689379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DSM-III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlates.
    Flick SN; Roy-Byrne PP; Cowley DS; Shores MM; Dunner DL
    J Affect Disord; 1993 Feb; 27(2):71-9. PubMed ID: 8440809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organization of co-occurring Axis II features in borderline personality disorder.
    Critchfield KL; Clarkin JF; Levy KN; Kernberg OF
    Br J Clin Psychol; 2008 Jun; 47(Pt 2):185-200. PubMed ID: 17845740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substance use disorders.
    Grilo CM; Martino S; Walker ML; Becker DF; Edell WS; McGlashan TH
    Am J Psychiatry; 1997 Sep; 154(9):1305-7. PubMed ID: 9286195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSM-III-R axis II comorbidity in dysthymia and major depression.
    Pepper CM; Klein DN; Anderson RL; Riso LP; Ouimette PC; Lizardi H
    Am J Psychiatry; 1995 Feb; 152(2):239-47. PubMed ID: 7840358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence, age distribution and comorbidity of personality disorders in Australian women.
    Quirk SE; Berk M; Pasco JA; Brennan-Olsen SL; Chanen AM; Koivumaa-Honkanen H; Burke LM; Jackson HJ; Hulbert C; A Olsson C; Moran P; Stuart AL; Williams LJ
    Aust N Z J Psychiatry; 2017 Feb; 51(2):141-150. PubMed ID: 27245936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.
    Zanarini MC; Frankenburg FR; Hennen J; Reich DB; Silk KR
    Am J Psychiatry; 2004 Nov; 161(11):2108-14. PubMed ID: 15514413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders.
    Skodol AE; Oldham JM; Gallaher PE
    Am J Psychiatry; 1999 May; 156(5):733-8. PubMed ID: 10327906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
    Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
    J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive dependency and depression: is the relationship specific?
    Skodol AE; Gallaher PE; Oldham JM
    J Nerv Ment Dis; 1996 Mar; 184(3):165-71. PubMed ID: 8600220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conduct disorder, substance use disorders, and coexisting conduct and substance use disorders in adolescent inpatients.
    Grilo CM; Becker DF; Fehon DC; Edell WS; McGlashan TH
    Am J Psychiatry; 1996 Jul; 153(7):914-20. PubMed ID: 8659614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axis I psychiatric symptoms associated with HIV infection and personality disorder.
    Johnson JG; Williams JB; Rabkin JG; Goetz RR; Remien RH
    Am J Psychiatry; 1995 Apr; 152(4):551-4. PubMed ID: 7694903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comorbidity of multiple personality disorder and DSM-III-R axis II disorders.
    Fink D
    Psychiatr Clin North Am; 1991 Sep; 14(3):547-66. PubMed ID: 1946024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.